Fasching P, Jackisch C, Rhiem K. et al
GeparOLA: A randomized phase II trial to assess the efficacy of paclitaxel and olaparib in comparison to paclitaxel/carboplatin followed by epirubicin/cyclophosphamide as neoadjuvant chemotherapy in patients (pts) with HER2-negative early breast cancer (BC) and homologous recombination deficiency (HRD).
J Clin Oncol 2019;
37 (Suppl.): Abstr. 506
Download Bibliographical Data